JACC: Advances - Comparison of Short-Term Health Care Utilization Between Telemedicine-Delivered vs In-Person Care Visits for Heart Failure
Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
JACC: CardioOncology Deputy Editor Ronald Witteles, MD and Mazen Hanna, MD discuss some of the latest data from the 2024 International Society of Amyloidosis meeting.
Mamas Mamas, DPhil, MA, MBBCh and Joerg Herrmann, MD discuss the care of patients with ischemic heart disease and cancer.
JACC: CardioOncology Deputy Editor Ronald Witteles, MD and Mathew Maurer, MD discuss the present and future state of ATTR amyloidosis diagnosis and treatment.
Commentary by Dr. Pratik Doshi and JACC: Clinical Electrophysiology Deputy Editor Dr. Ratika Parkash discussing how the new age of AFib guidelines affect clinical practice.
Commentary by Dr. Emile Daoud
Commentary by Trejeeve Martyn and Julia Simkowski
Commentary by Michelle Johnson
Commentary by Sadeer Al-Kindi
Commentary by Arnethea Sutton & Avirup Guha
Audio Summary of the June Issue with Introduction by Dr. Bonnie Ky
Commentary by Ashish Kumar
Audio Summary by Dr Yuwen Chen
Audio Summary of the June 1, 2024 Issue by Dr. Jian'an Wang
Commentary by Dr Steven Ho Man Lam
Commentary by Dr Dong Zhao
William Dale, MD, PhD, Supriya Gupta Mohile, MD, MS and Efrat Dotan, MD discuss how to effectively care for older adults with cancer, incuding challenges and opportunities for the field of cardio-oncology. Moderated by Nicholas Wilcox, MD, MHS.
JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC interviews Steven Petrow, an award-winning journalist and book author, who shares his moving story and personal experiences as a survivor of cancer.
Commentary by Dr. Abdullah Al-Abcha and Dr. Emmanouil S. Brilakis
Commentary by Dr. Abdullah Al-Abcha and Dr. Tanush Gupta
Commentary by Dr. Emile Daoud
JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and Dinesh Thavendiranathan, MD, MSc, Husam Abdel-Qadir, MD, PhD and Christopher Yu, MBBS discuss recent studies of SGLT2 inhibitors and withdrawal of neurhormonal therapy for cancer therapy-related cardiotoxicity.
Commentary by Dr. Abdullah Al-Abcha and Dr. Madjid Boukantar